PRVB News and Press, Provention Bio Inc. From 10/03/19

Provention Bio ( PRVB ) is a speculative biotech that you should definitely look into for the coming months. That's because there are a lot of moving parts for this biotech that could provide significant upside for investors. That's because the goal is for the biotech to meet with the FDA in...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

Investment Thesis With its low up-front costs, Omnipod of Insulet Corporation ( PODD ) has positioned itself to become diabetics’ first choice in pump therapy as they wean off the daily injections. The company’s top line has expanded at a compound annual growth rate ((CAGR)...

OLDWICK, N.J. , Sept. 25, 2019 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that management will present at the 2019 Cantor Global Healthcare Conference on...

OLDWICK, N.J. , Sept. 24, 2019 /PRNewswire/ -- Provention Bio, Inc., (Nasdaq: PRVB), a clinical-stage biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today reiterated its regulatory strategy regarding PRV-031 (teplizumab) for the prev...

Gainers:  AIM ImmunoTech (NYSEMKT: AIM ) +56% . Eros International Plc (NYSE: EROS ) +32% . Westwater Resources (NASDAQ: WWR ) +25% . ReneSola Ltd (NYSE: SOL ) +19% . Edesa Biotech (NASDAQ: EDSA ) +19% . Global Ship Lease (NYSE: GSL ) +15% . Lineage Cell Therapeutics (NYSEMKT: L...

SPI Energy (NASDAQ: SPI ) -13% . More news on: SPI Energy Co., Ltd., United States Steel Corporation, Provention Bio, Inc., Stocks on the move, Read more ...

Provention Bio (NASDAQ: PRVB ) prices its public offering of 5M common shares at $8/share for gross proceeds of $40M. More news on: Provention Bio, Inc., Healthcare stocks news, Read more ...